1. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. (25th January 2022) Authors: Kraynyak, Kimberly A; Blackwood, Elliott; Agnes, Joseph; Tebas, Pablo; Giffear, Mary; Amante, Dinah; Reuschel, Emma L; Purwar, Mansi; Christensen-Quick, Aaron; Liu, Neiman; Andrade, Viviane M; Diehl, Malissa C; Wani, Snehal; Lupicka, Martyna; Sylvester, Albert; Morrow, Matthew P; Pezzoli, Patrick... Journal: Journal of infectious diseases Issue: Volume 225:Number 11(2022) Page Start: 1923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗